Passage BIO (PASG) Cash from Investing Activities (2019 - 2026)

Passage BIO's Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $20000.0 for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 99.95% year-over-year to $20000.0; the TTM figure through Mar 2026 stood at $605000.0 (down 99.13% YoY), while the FY2025 annual figure was $40.2 million, down 26.81% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $20000.0, down from $585000.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $39.6 million in Q1 2025, with the low at -$4.8 million in Q3 2022.
• The 5-year median for Cash from Investing Activities is $14.0 million (2023), against an average of $12.4 million.
• The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities soared 571.86% in 2023, then tumbled 99.95% in 2026.
• Passage BIO's Cash from Investing Activities stood at -$3.4 million in 2022, then soared by 326.33% to $7.6 million in 2023, then jumped by 79.97% to $13.7 million in 2024, then sank by 95.72% to $585000.0 in 2025, then tumbled by 96.58% to $20000.0 in 2026.
• Business Quant data shows PASG's Cash from Investing Activities at $20000.0 in Q1 2026, $585000.0 in Q2 2025, and $39.6 million in Q1 2025.